Introduction {#Sec1}
============

Invalidation is a common experience in people with a rheumatic disease. It includes non-acceptance by others, misunderstanding, disbelief, rejection, stigmatization, and suspicion that the problem is exaggerated or psychological \[[@CR1]\]. Two major dimensions of invalidation have been identified: lack of understanding and discounting \[[@CR2]\]. Lack of understanding reflects a lack of positive responses such as not recognizing, not comprehending, and not emotionally supporting the person. Discounting represents negative social responses and social rejection, including disbelieving, admonishing, dismissing inability to work, not acknowledging symptom fluctuations, and offering unusable advice. In rheumatic diseases, invalidation is related to worse physical and mental health \[[@CR3], [@CR4]\]. Pain and fatigue, which are the main symptoms in rheumatic diseases, are mostly not observable \[[@CR5]\]. Therefore, symptoms and the consequent burden in people with rheumatic diseases are often poorly acknowledged and understood by others.

Invalidation depends on both the response of others to a person (objective invalidation) and on the appraisal that the person makes of such a response (subjective invalidation). To reduce objective invalidation, people near the patient should not deny the existence of what cannot be observed and they should not lecture, patronize, or overprotect the person. Instead they should listen, try to understand, and acknowledge the disorder and the person, and help (instrumental), comprehend and emotionally support the person. However, severity of invalidation not only depends on the actual invalidation by the social environment but also on the perception and skills of the person. This article focuses on subjective evaluation of invalidation and on skills that may help people to experience less invalidation.

To support people in dealing with adversities in life, management options are commonly derived from two broad treatment modalities: classical cognitive behavioral therapy (CBT) and acceptance and commitment therapy (ACT). CBT aims at increasing coping skills by promoting helpful thoughts and behavior \[[@CR6]\]. ACT aims at accepting difficulties and to be committed to make changes in daily life that are in agreement with one's life values \[[@CR7]\]. Among the individual differences that may influence the experience of invalidation, self-efficacy \[[@CR8]\] and acceptance \[[@CR9], [@CR10]\] skills are more or less prototypical for these CBT and ACT modalities, respectively. In the current study, self-efficacy and acceptance are operationalized as chronic disease self-efficacy and pain acceptance.

Self-efficacy is the personal belief that one can successfully perform particular behaviors to achieve a goal \[[@CR11]\], such as managing pain \[[@CR8]\] or managing daily challenges \[[@CR12]\] and the consequences of a rheumatic disease \[[@CR13]--[@CR15]\]. Chronic disease self-efficacy has been related to less health distress, illness intrusiveness, activity limitation, depression and fatigue \[as summarized in [@CR16]\]. In analogy to these observed correlations, it is our hypothesis that self-efficacy to deal with a chronic disease is also related to less invalidation.

Pain acceptance, entails an active willingness to engage in meaningful activities in life despite having pain, and a reduction of unsuccessful attempts to avoid or control pain \[[@CR17]\]. Greater pain acceptance has been related to less attention to pain \[[@CR18]\], lower levels of pain-related anxiety and avoidance, less depression, and less physical and psychosocial disability \[[@CR19]--[@CR21]\]. Acceptance was also indicated to buffer the effect of negative affect on pain levels \[[@CR9]\]. We chose pain acceptance as a measure of acceptance, because for any person with fibromyalgia, chronic pain is a primary symptom one needs to deal with, and a questionnaire to measure pain acceptance is available \[[@CR22]\]. People who are able to accept their pain are assumed to be less in need of validation by others. Therefore, we hypothesize that people who accept their pain more are less likely to experience invalidating responses by others.

People who have a flexible repertoire of abilities are assumed to best deal with different kinds of unsatisfactory situations \[[@CR23]\]. High coping skills such as reflected in chronic disease self-efficacy will make people feel competent to deal with situations in which control of invalidation is possible, while high acceptance skills will help people to actively and in full awareness experience even adverse situations without unnecessary attempts to change their frequency or form \[[@CR7]\], which is a desirable skill when situations are hard to control.

Therefore, the aim of the present study was to examine the association of self-efficacy and pain acceptance with invalidation in people with a rheumatic disease. We hypothesized that high chronic disease self-efficacy and high pain acceptance are additively associated with low invalidation. Moreover, we hypothesized that people with both high chronic disease self-efficacy and high pain acceptance will experience a particularly low level of invalidation, which will be shown in a significant prediction of invalidation from the interaction between chronic disease self-efficacy and pain acceptance. Our cross-sectional design only allows correlational analyses and interpretations. We do not have the intention of establishing or implying causality. However, if the present study shows that self-efficacy and pain acceptance are associated with less invalidation, this will stimulate the design of prospective studies and therapies to test whether these factors help in dealing with invalidation.

Methods {#Sec2}
=======

Participants and procedure {#Sec3}
--------------------------

The study was conducted according to the principles of the Declaration of Helsinki \[[@CR24]\] and approved by the medical ethical review board of the University Medical Center Utrecht (Utrecht, The Netherlands). The study is part of an international online research project on invalidation in rheumatic diseases \[[@CR25]\]. Participants were invited to take part in an online survey via a recruitment notice on websites of patient associations for rheumatic diseases located in various nations. The recruitment notice included information about the aim and content of the study, inclusion criteria, duration of participation (about 20 min), confidentiality, and a hyperlink to the online questionnaire. Participants could decide to participate after being informed about the study and were able to stop at any point if they desired to do so.

Each language version of the online research project had different questionnaires included next to the standard questionnaire package. The Spanish version included the questionnaire 'Chronic Pain Acceptance Questionnaire (CPAQ)' and 'Spanish Chronic Disease Self-Efficacy Scale (SEMCD-S)' to be able to study these concepts in relation to invalidation.

Inclusion criteria were (1) to report being diagnosed of at least one rheumatic disease by a health professional, (2) to be at least 18 years old, and (3) to have invalidation (discounting and lack of understanding) scores from at least three out of five sources of invalidation. This was done because calculating a mean invalidation score for one or two sources would have been less reliable \[[@CR4]\]. Of the initial 1623 people of Spanish speaking countries who started with the online questionnaire, 1153 participants (71%) were included. The 470 participants were excluded for the following reasons: for 199 participants it was unknown whether the rheumatic disease was diagnosed by a health professional, 20 participants were younger than 18 years, 85 participants did not fill out the invalidation questionnaire, 136 participants had filled out less than three sources of the invalidation questionnaire, and 30 participants had submitted the questionnaires two or more times as was shown by a similar e-mail address, IP address, and year of birth.

Demographic and health-related characteristics of the sample are shown in Table [1](#Tab1){ref-type="table"}. Most participants were female (91%) and with an average age of 45.4 (range = 18--82) years. Our dataset included the total years of received education since the age of 4. Education levels were estimated using the number of years it commonly takes to pass each level of the Spanish education system: primary level 1--8 years, secondary level 9--14 years, and tertiary level \> 14 years.Table 1Characteristics of participants (*N* = 1153)Gender: female, *n* (%)1045 (90.6)Gender: male, *n* (%)108 (9.4)Age, mean (SD) years45.4 (10.5)Education level, *n* (%) Primary, 1--8 years education after 4 years of age7 (0.6) Secondary, 9--14 years education after 4 years of age377 (32.7) Tertiary, \> 14 years education after 4 years of age769 (66.7)Invalidation (3\*I), mean (SD) Discounting2.64 (0.82) Lack of understanding2.60 (0.81)Self-efficacy (SEMCD-S), mean (SD)4.78 (2.23)Pain acceptance (CPAQ), mean (SD)2.84 (0.83)Rheumatic disease, *n* (%) Fibromyalgia388 (33.7) Rheumatoid arthritis111 (9.6) Ankylosing spondylitis63 (5.5) Systemic lupus erythematosus124 (10.8) Sjögren's syndrome35 (3.0) A single other rheumatic disease69 (6.0) Fibromyalgia and another rheumatic disease258 (22.4) Multiple rheumatic diseases; not fibromyalgia105 (9.1)*SD* standard deviation, *SEMCD-S* Spanish Chronic Disease Self-efficacy Scale, *CPAQ* Chronic Pain Acceptance Questionnaire, *3\*I* Illness Invalidation Inventory

Instruments {#Sec4}
-----------

The Illness Invalidation Inventory \[3\*I; [@CR2]\] was used to measure the degree of invalidation on the two domains 'Discounting' and 'Lack of Understanding' using the same eight items to refer to five potential sources of invalidation: Spouse, Family, Medical professionals, Work, and Social services. An example item is 'My family thinks I should be tougher'. The items of the 3\*I are answered on a 5-point Likert scale ranging from 'Never' (1) to 'Very often' (5). A high score means a high level of invalidation. The internal consistency of the 3\*I can be classified as good \[[@CR2], [@CR26]\]. In the current study, the internal consistency was high for the sources of lack of understanding (three items, Spouse; *α* = 0.85, Family; *α* = 0.85, Medical professionals; *α* = 0.86, Work; α = 0.78, Social services; α = 0.86) and discounting (five items, Spouse; *α* = 0.75, Family; *α* = 0.81, Medical professionals; *α* = 0.82, Work; *α* = 0.85, Social services; *α* = 0.88). If a particular source of invalidation did not apply to them during the past year (e.g., because they did not have a spouse or work), then the patient was instructed to skip that part of the questionnaire. Mean scores for lack of understanding and discounting were calculated across the (at least three) available sources of invalidation \[[@CR4]\].

The SEMCD-S \[[@CR16], [@CR27]\] measures self-efficacy in people with a chronic disease. The Spanish version consists of four items instead of the original six items, because the internal consistency was higher when excluding two items with the lowest item-to-scale correlations \[[@CR28]\]. An example of an item is: 'How confident are you that you can keep the fatigue caused by your disease from interfering with the things you want to do?' Items are rated on an 11-point Likert scale ranging from 0 (never true) to 10 (always true). A high score reflects a higher level of self-efficacy. Reliability and validity of SEMCD-S were indicated to be good \[[@CR16]\]. Internal consistency in the current study was very good (*α* = 0.91).

The brief 20-item version of the CPAQ \[[@CR22]\] was used to measure pain acceptance. The questionnaire includes two dimensions: The Activity Engagement subscale (11 items) measures participation in daily activities while acknowledging the presence of pain, and the Pain Willingness subscale (9 items) that measures the degree to which pain is allowed in experience without efforts to avoid or control it. In the current study, to prevent that the model is obstructed by shared variance of two correlated predictor variables and to be able to compare one score that is characteristic for pain acceptance with one self-efficacy score, we used the total score for pain acceptance, i.e., the sum of the scores at both dimensions. Example items are: 'My life is going well, even though I have chronic pain' and 'I need to concentrate on getting rid of my pain' (reversed sign). The items are rated on a 7-point Likert scale from 0 (never true) to 6 (always true). A high score means a high acceptance of pain. Reliability and validity of the CPAQ subscales have been indicated to be good \[[@CR22]\]. Internal consistency of the total score for pain acceptance in the current study was good (*α* = 0.79).

Cutoff values for invalidation, self-efficacy, and pain acceptance {#Sec5}
------------------------------------------------------------------

To describe participants' levels of invalidation, self-efficacy, and pain acceptance as either 'high' or 'low', cutoff values were set by the authors at the middle of the response scales: 3.0 for discounting and lack of understanding (invalidation), 5.5 for self-efficacy, and 3.0 for pain acceptance. Lower scores on the two dimensions of invalidation and higher scores on self-efficacy and pain acceptance are more favorable.

Statistical analyses {#Sec6}
--------------------

Statistical analyses were done with the Statistical Package for Social Sciences (SPSS version 21.0). Significance levels were set at *p* \< 0.05 (two-tailed). The residual plots in regression analyses showed that the assumptions of linearity and normality were met (data not shown).

To test our hypotheses that self-efficacy, pain acceptance, and the interaction of self-efficacy and pain acceptance are associated with low invalidation, multiple hierarchical regression analyses were performed for discounting and lack of understanding separately. In Block 1, the demographic variables age, education level and gender were entered. Centered scores of self-efficacy and pain acceptance were entered in Block 2. In Block 3, the self-efficacy × pain acceptance interaction was entered, and in Block 4, fibromyalgia was entered to check whether results were not due to having a fibromyalgia diagnosis, because invalidation is experienced more often by people with fibromyalgia than by people with other rheumatic diseases \[[@CR2]\].

Results {#Sec7}
=======

Percentage deviating scores {#Sec8}
---------------------------

Figure [1](#Fig1){ref-type="fig"} depicts percentages of people with low self-efficacy, low pain acceptance, high discounting, and high lack of understanding per specific rheumatic disease.Fig. 1Percentages of participants with low self-efficacy, low pain acceptance, high discounting, and high lack of understanding per rheumatic disease; \**p* \< 0.05, \*\* *p* \< 0.01, \*\*\* *p* \< 0.001

Hierarchical regression analyses {#Sec9}
--------------------------------

Table [2](#Tab2){ref-type="table"} shows the results of the hierarchical regression analyses examining whether both dimensions of invalidation separately (discounting and lack of understanding) were associated with gender, age, education, self-efficacy, pain acceptance, the interaction of self-efficacy and pain acceptance, and fibromyalgia. The regression model for discounting showed that, in Block 1, gender and education were not associated with discounting while a higher age was associated with lower discounting (*t* = − 2.03, *p* = 0.042). In Block 2, higher levels of self-efficacy (*t* = − 4.80, *p* = \< 0.001) and pain acceptance (*t* = − 7.99, *p* = \< 0.001) were both additively associated with lower levels of discounting. One unit increase on self-efficacy and pain acceptance were associated with 0.06 and 0.25 units decrease on discounting. In Block 3, the interaction of self-efficacy and pain acceptance had no significant association with discounting (*t* = − 1.79, *p* = 0.072). In Block 4, although fibromyalgia was associated with more discounting (*t* = 6.39, *p* = \< 0.001), the relation of discounting with self-efficacy and pain acceptance remained intact after inclusion of the fibromyalgia diagnosis in the model.Table 2Hierarchical regression analyses predicting the two dimensions of invalidation, discounting and lack of understanding, from demographic variables, self-efficacy, pain acceptance, and fibromyalgia in 1153 people with rheumatic diseasesVariableDiscounting (3\*I)Lack of understanding (3\*I)*bβ*Adj. *R* ^2^*bβ*Adj. *R* ^2^Block 10.0010.003 Gender0.0500.083− 0.138− 0.049 Age− 0.005\*0.0020.0040.055 Education (low)0.1810.3120.1780.017 Education (high)0.0360.0520.0610.035Block 20.131\*\*\*0.102\*\*\* Gender0.0200.077− 0.156\*− 0.056 Age− 0.0040.0020.005\*0.067 Education (low)0.1020.2910.0970.009 Education (high)0.100\*0.0480.118\*0.069 Self-efficacy (SEMCD-S)− 0.057\*\*\*0.012− 0.065\*\*\*− 0.178 Pain acceptance (CPAQ)− 0.254\*\*\*0.032− 0.183\*\*\*− 0.187Block 30.132\*\*\*0.104\* Gender0.0180.077− 0.159\*− 0.057 Age− 0.0040.0020.005\*0.067 Education (low)0.1080.2910.1040.010 Education (high)0.099\*0.0480.117\*0.068 Self-efficacy (SEMCD-S)− 0.056\*\*\*0.012− 0.064\*\*\*− 0.174 Pain acceptance (CPAQ)− 0.253\*\*\*0.032− 0.182\*\*\*− 0.186 Self-efficacy × pain acceptance− 0.0200.011− 0.024\*− 0.060Block 40.162\*\*\*0.136\*\*\* Gender0.0920.077− 0.082− 0.029 Age− 0.008\*\*\*0.0020.0020.021 Education (low)0.0940.2860.0890.009 Education (high)0.101\*0.0480.118\*0.069 Self-efficacy (SEMCD-S)− 0.047\*\*\*0.012− 0.054\*\*\*− 0.149 Pain acceptance (CPAQ)− 0.216\*\*\*0.032− 0.144\*\*\*− 0.147 Self-efficacy × pain acceptance− 0.0210.011− 0.025\*− 0.063 Fibromyalgia0.309\*\*\*0.0480.320\*\*\*0.196Education level, number of years education after 4 years of age: primary 1--8 years (low), secondary 9--14 years (middle), tertiary \> 14 years (high)*SEMCD-S* Spanish Chronic Disease Self-efficacy Scale, *CPAQ* Chronic Pain Acceptance Questionnaire, *3\*I* Illness Invalidation Inventory\**p* \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001

The regression model for lack of understanding showed that, in Block 1, neither gender nor age or education were associated with lack of understanding. In Block 2, higher levels of self-efficacy (*t* = − 5.41, *p* = \< 0.001) and pain acceptance (*t* = − 5.71, *p* = \< 0.001) were additively associated with lack of understanding. One unit increase on self-efficacy and pain acceptance were associated with 0.07 and 0.18 units decrease on lack of understanding. In Block 3, the interaction of self-efficacy and pain acceptance was associated with lack of understanding (*t* = − 2.12, *p* = 0.034). Figure [2](#Fig2){ref-type="fig"} displays the interaction effect. The graph shows that particularly people who had both high self-efficacy and high pain acceptance perceived the least lack of understanding. In Block 4, although fibromyalgia was associated with higher lack of understanding (*t* = 6.55, *p* = \< 0.001), the relation of discounting with self-efficacy and pain acceptance remained intact after the inclusion of fibromyalgia diagnosis in the model.Fig. 2Invalidation (discounting and lack of understanding) predicted by self-efficacy and pain acceptance in 1153 people with rheumatic diseases

Discussion {#Sec10}
==========

To establish whether both self-efficacy and pain acceptance may buffer against invalidation, our study examined the relationship of the two factors with invalidation. Our findings confirm that the level of invalidation is lower among people with rheumatic diseases with a higher level of either self-efficacy or pain acceptance. Moreover, people with both high self-efficacy and high pain acceptance showed even lower invalidation: the combination of high self-efficacy and high pain acceptance was significantly associated with low lack of understanding. This interaction was not significant for discounting.

Since the seminal work of Bandura \[[@CR11]\] on self-efficacy, it has been shown that self-efficacy helps in dealing with numerous adversities \[[@CR8], [@CR12], [@CR29]\] and that self-efficacy is an important component of self-management in chronic diseases \[[@CR30]\] including rheumatic diseases \[[@CR31]\]. Our correlational observation does not allow causal interpretations. The association may reflect that confidence to effectively deal with the disease and its consequences includes competency to deal with invalidation but it may also reflect that receiving less invalidation is positive for one's confidence to deal with disease. In previous research, self-efficacy has been shown to be associated with self-management and the outcome of self-management programs \[[@CR32], [@CR33]\]. Moreover, a self-management program was shown to increase self-efficacy to manage pain \[[@CR34]\]. This suggests that it is worth trying to reduce invalidation by increasing self-efficacy skills to deal with the disease and invalidation, which should be evaluated in future research.

Having taken account of chronic disease self-efficacy, our study showed that pain acceptance was additively associated with invalidation. Likely the higher scores on acceptance of pain reflect a general flexible willingness of people to have undesirable experiences without attempting to control them \[[@CR35]\]. While the restructuring of cognitions and behavior is a fruitful approach to help people to deal with situations that can be changed, it is an asset if the acceptance of the inevitable consequences of the disease is part of people's coping repertoire to deal with situations that cannot be changed \[[@CR20], [@CR36]\]. On the other hand, it is also possible that people who are able to accept their pain and pursuit their goals actually receive less invalidation from others. In recent years, Acceptance and Commitment Therapy \[[@CR7]\] has been applied in the treatment of problems that may accompany chronic somatic diseases, including several rheumatic diseases \[[@CR37]\]. This therapy helps people to accept the difficulties that come with a chronic disease and to be committed to make changes in daily life that are in agreement with one's life values. Toon van Helmond (Sint Maartenskliniek, Nijmegen, the Netherlands) proposed a model of dealing with invalidation in which the first steps consist of communication and the final step involves acceptance as the best way to deal with invalidation when it is difficult to change the environment \[[@CR38]\]: Fig. [3](#Fig3){ref-type="fig"}. Ideally, a person has the flexibility to deal effectively with invalidation as well as to accept it when the situation cannot be changed as was indicated by our finding that the combination of high chronic disease self-efficacy and high pain acceptance was associated with low lack of understanding.Fig. 3Recommendations to deal with invalidation (by Toon van Helmond, Sint Maartenskliniek, Nijmegen, The Netherlands)

In our study high invalidation, low chronic disease self-efficacy, and low pain acceptance were more prominent in fibromyalgia than in other rheumatic diseases (data analyses not shown), which was expected because of the invisibility of signs of the disease and its pathological substrate. However, in all disease groups, using the middle of the response scale as cutoff criterion, a minimum of 38% showed low pain acceptance, 45% low chronic disease self-efficacy, 23% high discounting, and 11% a high lack of understanding. This clearly shows that health care professionals should be alert to the burden of invalidation in all rheumatic diseases. Moreover, our data suggest that it is worth trying to decrease invalidation by stimulating chronic disease self-efficacy and pain acceptance skills in self-management training, educational materials, and interventions in patients with rheumatic diseases.

Although no causality can be inferred from the cross-sectional design of our study, the results are valuable because they give an indication of the prevalence of three aspects that are considered core to adjustment to chronic disease \[[@CR5]\] and because the results indicate who might be better protected against invalidation. Future studies with a prospective or clinical experimental design are needed to clarify the causal direction of the observed associations. Furthermore, it would be worthwhile to examine more specifically whether patients with a rheumatic disease and high invalidation scores can be helped by acquiring skills of accepting invalidation (instead of or besides to pain acceptance) and by increasing self-efficacy regarding invalidation (instead of or besides self-efficacy in dealing with a chronic disease). A methodological limitation of the studied sample is that inclusion was based on self-reported diagnoses of rheumatic diseases without certification by a medical specialist. Moreover, the recruitment through the internet may have led to a lower representation of the older population and people with a low social economic class. Finally, people with fibromyalgia were overrepresented in this study. However, the findings in the regression analyses remained intact when the regressions were adjusted for a fibromyalgia diagnosis and demographic characteristics.

The current study shows that invalidation, low chronic disease self-efficacy, and low pain acceptance are prominent in fibromyalgia and other rheumatic diseases, and that invalidation is low in people with higher chronic disease self-efficacy and higher pain acceptance. Additionally, people with both higher chronic disease self-efficacy and pain acceptance experience the lowest lack of understanding. The findings suggest that it is useful to examine whether interventions aimed at increasing chronic disease self-efficacy and pain acceptance help people with rheumatic diseases for whom invalidation is a considerable burden.
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